Matches in SemOpenAlex for { <https://semopenalex.org/work/W951285037> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W951285037 abstract "Introduction : Elevated resting heart rate (HR) is associated with increased risk for cardiovascular morbidity and mortality. Erectile dysfunction is associated with endothelial dysfunction and atherosclerosis due to similar risk factors. We hypothesized that HR reduction may influence endothelial- and erectile function and tested the effects of the I f -current inhibitor ivabradine in ApoE−/− mice. Methods and Results: Male ApoE−/− mice fed a high-cholesterol diet were treated with ivabradine (iva) (10 mg/kg/d p.o.) or vehicle (n=10 per group) for 6 weeks. Treatment with ivabradine reduced HR by 13.4% (iva 472±9 bpm vs vehicle 545±11 bpm, p<0.01). High cholesterol feeding led to severe atherosclerosis in the aortic sinus and the aorta. Ivabradine reduced atherosclerotic plaque size in the aortic root from 32±4% to 18±2% and in the ascending aorta from 26±4% to 7±1% (p<0,05). Endothelium dependent relaxation of aortic rings and corpora cavernosa to carbachol was significantly improved in ivabradine fed ApoE−/− mice compared to controls (p<0.01). Aortic eNOS mRNA expression, quantified by real time PCR with the TaqMan system was upregulated to 156±11% (p<0.05) in aortic rings after treatment with ivabradine. HR reduction led to attenuation of NADPH oxidase activity to 48±6% as measured by a lucigenin-enhanced chemiluminescence assay and decreased L-012 chemiluminescence to 24±9% (both p<0.05). Lipidperoxidation was reduced to 65±8% in the vasculature of the iva group compared to vehicle treatment (p<0.05). DHE fluorescence microscopy in aortic sections detected reduction of ROS release to 62±4% in ivabradine treated mice (p<0.01). Conclusions : Selective HR reduction improves endothelial as well as erectile function and reduces atherosclerotic plaque formation in ApoE−/− mice. Those functional effects are mediated by decreased oxidative stress and upregulation of endothelial NOS (eNOS). These results identify HR as a risk factor for vascular disease and support the importance of heart rate reduction in vascular prevention." @default.
- W951285037 created "2016-06-24" @default.
- W951285037 creator A5010490795 @default.
- W951285037 creator A5011003633 @default.
- W951285037 creator A5014343012 @default.
- W951285037 creator A5014737994 @default.
- W951285037 creator A5021420835 @default.
- W951285037 creator A5060197316 @default.
- W951285037 creator A5060503236 @default.
- W951285037 date "2007-10-16" @default.
- W951285037 modified "2023-09-25" @default.
- W951285037 title "Abstract 477: Selective Heart Rate Reduction Via Inhibition Of The I F -current Prevents Atherosclerosis And Improves Endothelial And Erectile Function In Apoe −/− Mice" @default.
- W951285037 doi "https://doi.org/10.1161/circ.116.suppl_16.ii_81-a" @default.
- W951285037 hasPublicationYear "2007" @default.
- W951285037 type Work @default.
- W951285037 sameAs 951285037 @default.
- W951285037 citedByCount "0" @default.
- W951285037 crossrefType "journal-article" @default.
- W951285037 hasAuthorship W951285037A5010490795 @default.
- W951285037 hasAuthorship W951285037A5011003633 @default.
- W951285037 hasAuthorship W951285037A5014343012 @default.
- W951285037 hasAuthorship W951285037A5014737994 @default.
- W951285037 hasAuthorship W951285037A5021420835 @default.
- W951285037 hasAuthorship W951285037A5060197316 @default.
- W951285037 hasAuthorship W951285037A5060503236 @default.
- W951285037 hasConcept C126322002 @default.
- W951285037 hasConcept C134018914 @default.
- W951285037 hasConcept C164705383 @default.
- W951285037 hasConcept C2776992346 @default.
- W951285037 hasConcept C2777622882 @default.
- W951285037 hasConcept C2777953023 @default.
- W951285037 hasConcept C2778326061 @default.
- W951285037 hasConcept C2779134260 @default.
- W951285037 hasConcept C2779167562 @default.
- W951285037 hasConcept C2779980429 @default.
- W951285037 hasConcept C2780972559 @default.
- W951285037 hasConcept C519581460 @default.
- W951285037 hasConcept C57089818 @default.
- W951285037 hasConcept C71924100 @default.
- W951285037 hasConcept C84393581 @default.
- W951285037 hasConceptScore W951285037C126322002 @default.
- W951285037 hasConceptScore W951285037C134018914 @default.
- W951285037 hasConceptScore W951285037C164705383 @default.
- W951285037 hasConceptScore W951285037C2776992346 @default.
- W951285037 hasConceptScore W951285037C2777622882 @default.
- W951285037 hasConceptScore W951285037C2777953023 @default.
- W951285037 hasConceptScore W951285037C2778326061 @default.
- W951285037 hasConceptScore W951285037C2779134260 @default.
- W951285037 hasConceptScore W951285037C2779167562 @default.
- W951285037 hasConceptScore W951285037C2779980429 @default.
- W951285037 hasConceptScore W951285037C2780972559 @default.
- W951285037 hasConceptScore W951285037C519581460 @default.
- W951285037 hasConceptScore W951285037C57089818 @default.
- W951285037 hasConceptScore W951285037C71924100 @default.
- W951285037 hasConceptScore W951285037C84393581 @default.
- W951285037 hasIssue "suppl_16" @default.
- W951285037 hasLocation W9512850371 @default.
- W951285037 hasOpenAccess W951285037 @default.
- W951285037 hasPrimaryLocation W9512850371 @default.
- W951285037 hasRelatedWork W1981812658 @default.
- W951285037 hasRelatedWork W2096421784 @default.
- W951285037 hasRelatedWork W2099366831 @default.
- W951285037 hasRelatedWork W2141998216 @default.
- W951285037 hasRelatedWork W2150522638 @default.
- W951285037 hasRelatedWork W2160510592 @default.
- W951285037 hasRelatedWork W2275976839 @default.
- W951285037 hasRelatedWork W2345047262 @default.
- W951285037 hasRelatedWork W2569682869 @default.
- W951285037 hasRelatedWork W2972838522 @default.
- W951285037 hasVolume "116" @default.
- W951285037 isParatext "false" @default.
- W951285037 isRetracted "false" @default.
- W951285037 magId "951285037" @default.
- W951285037 workType "article" @default.